Wenli Wang

ORCID: 0009-0008-4658-6648
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mycobacterium research and diagnosis
  • Tuberculosis Research and Epidemiology
  • Antibiotic Resistance in Bacteria
  • Hydraulic and Pneumatic Systems
  • Bone health and treatments
  • Infectious Diseases and Mycology
  • Pharmacological Effects and Toxicity Studies
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Infections and bacterial resistance
  • Quinazolinone synthesis and applications
  • Railway Engineering and Dynamics
  • Vibration Control and Rheological Fluids
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Berberine and alkaloids research
  • Parathyroid Disorders and Treatments

Hangzhou Red Cross Hospital
2024

Second Affiliated Hospital of Zhejiang University
2023

Hunan University
2015

Zhejiang University
2007-2015

University of Huddersfield
2015

Background. Bacteremias, which are often caused by gram‐negative bacteria, the most frequently occurring infectious complications after liver transplantation (LT). The aim of this study was to investigate bacteremic incidence, pathogenic spectrum, risk factors for bacteremia due multidrug resistant (MDR) bacilli, and its impact on mortality LT. Methods. A cohort analysis prospectively recorded data done in 475 LT recipients, who were divided into 3 categories: cases with bacteremia, MDR...

10.1111/j.1399-3062.2009.00421.x article EN Transplant Infectious Disease 2009-07-23

Mycobacterium abscessus (MAB) is intrinsically resistant to many antibiotics, but the evolution of acquired drug resistance poorly understood. We analyzed published genomes 5,617 clinical MAB isolates from 20 countries and searched for signals ongoing in 35 drug-resistance-associated genes. Of these, we found 14 genes were subject positive selection identified novel mutational sites under selection. Among erm(41) V80I mutation arose exclusively strains with 28T affected 50.5% (1750/3465)...

10.1093/infdis/jiae580 article EN The Journal of Infectious Diseases 2024-11-26

Abstract Some rifampicin-resistant Mycobacterium tuberculosis (MTB) strains were susceptible to rifabutin (RFB) and may be amenable treatment with RFB. We performed a meta-analysis of available cross-sectional studies determine which RIF-resistance mutations associated susceptibility. identified through PubMed, Web Science, Embase, Cochrane Library up June 1, 2023. Studies that met our criteria those investigated rpoB reported phenotypic drug susceptibility for RIF The relationship between...

10.1101/2023.07.13.548878 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-07-14
Coming Soon ...